Bioregulator Peptides Unveiled

Bill shares groundbreaking updates on his clinical trial involving bioregulator peptides and their potential to reverse biological age. The discussion delves into measuring telomere length and DNA methylation, while exploring a new hypothesis on the cellular mechanisms of aging. With decades of experience in longevity research, Bill's insights promise to reshape our understanding of health span and lifespan extension.